Logotype for AEVIS Victoria

AEVIS (AEVIS) H2 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for AEVIS Victoria

H2 2024 earnings summary

17 Jun, 2026

Executive summary

  • Achieved strong performance in 2024, marked by significant deleveraging, successful investment activity, and value creation across healthcare, hospitality, and real estate segments.

  • Statutory net profit reached CHF 26.5 million, reversing a prior year loss of CHF 8.8 million, with equity rising to CHF 573.4 million and an equity ratio of 70.1%.

  • Opened the Genolier Innovation Hub and completed key acquisitions, including Spital Zofingen and Centro Medico, expanding integrated care regions.

  • Hospitality segment delivered another record year with over 10% growth, and infrastructure portfolio remained stable with strategic asset sales.

  • Strategic partnerships, such as with Kantonsspital Aarau and Visana, enhanced integrated care and insurance offerings.

Financial highlights

  • Net profit reached CHF 26.5 million in 2024, reversing a prior year loss of CHF 8.8 million.

  • Equity increased to CHF 573.4 million (70.1% of assets), up from CHF 549.3 million (68.3%) year-over-year.

  • Book value of participations at CHF 656 million, with market value exceeding CHF 2 billion, indicating substantial hidden reserves.

  • Hospitality segment achieved organic growth of 10.1%, with revenue per room up 8.5% and average room rates at CHF 580.

  • Real estate EBITDA increased by 26%, and Infracore’s market value rose to over CHF 1.33 billion.

Outlook and guidance

  • Strong start to 2025 with 24.7% revenue growth in healthcare in the first two months, driven by acquisitions and 4% organic growth.

  • Continued focus on integration of new acquisitions and expansion of integrated care regions, with a third region planned for 2026.

  • Ongoing cost-cutting and efficiency programs are on track, with more than half of CHF 20 million savings already achieved.

  • No consolidated revenue or margin targets provided for 2025 due to macroeconomic uncertainties and investment diversity.

  • Dividend payments expected to resume from 2025, with 2024 profits prioritized for deleveraging.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more